Skip to content

The utility of 11C-choline PET/CT in prostate patients of PSA failure

The utility of 11C-choline PET/CT in prostate patients of PSA failure - 11C-choline PET/CT in PSA failure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019029
Enrollment
50
Registered
2015-10-01
Start date
2015-10-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Interventions

11C-choline PET/CT, pelvic MRI, chest/abdomen CT, bone scintigraphy

Sponsors

Radiology, Hyogo College of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: *The patients that the urology department chief physician judged an examination for 11C-Colin PET/CT to be necessary. *The patients who show PSA failure after the treatments. *The patients who underwent or will undergo pelvic MRI, chest/abdomen CT, bone scintigraphy. *The patients in good condition. *The patients who can understand study contents, and a written agreement is provided

Exclusion criteria

Exclusion criteria: *The patients who cannot keep face up position because of sharp pain in succession for around 30 minutes. *The patients with the extreme claustrophobia. *The patients whom the ADL which I become independent and can inspect is not kept. *The patients who a study person in charge is judged to be inappropriate.

Design outcomes

Primary

MeasureTime frame
To compare diagnostic accuracy (ROC analysis, sensitivity, specificity, and accuracy) for diagnosing lymph node recurrence between 11C-choline PET/CT and chest/abdomen CT.

Secondary

MeasureTime frame
To compare diagnostic accuracy (ROC analysis, sensitivity, specificity, and accuracy) for diagnosing local recurrence and distant metastasis and clinical impact between 11C-choline PET/CT and chest/abdomen CT.

Countries

Japan

Contacts

Public ContactKazuhiro Kitajima

Hyogo College of Medicine Nuclear Medicine and PET Center

ka-kitajima@hyo-med.ac.jp0798-45-6883

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026